PCOS and Hair Loss (2026): Why It Happens and What Actually Treats It

Last updated: May 2026 | Written by RK

There is a particular cruelty to how polycystic ovary syndrome affects hair. The same hormonal imbalance that thins the hair on a woman’s scalp simultaneously thickens it on her face, her chin, her chest and her abdomen. Hair where she does not want it; less hair where she does. It is one of the most distressing combinations in dermatology — and it is also one of the most misunderstood, because the obvious response (treat the scalp) misses the point. The hair is downstream. The hormones are the disease.

This guide explains why PCOS does this, what the scalp loss actually looks like, how it is diagnosed, and — crucially — which treatments work, because PCOS hair loss is genuinely treatable when you treat the PCOS. For the broader picture of women’s pattern hair loss, see the female pattern hair loss guide.

What PCOS is

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting an estimated 6–13% depending on the diagnostic criteria used — roughly one in eight — and a large fraction of cases remain undiagnosed [1]. Despite the name, it is not really about ovarian cysts; it is a disorder of hormones and metabolism in which the ovaries are one affected organ among several.

It is diagnosed using the Rotterdam criteria, which require any two of the following three features [2]:

1. Irregular or absent ovulation — irregular, infrequent, or absent periods.
2. Hyperandrogenism — either clinical signs (hirsutism, acne, scalp hair loss) or elevated androgen levels on a blood test.
3. Polycystic ovarian morphology — the characteristic multifollicular appearance on ultrasound.

The feature that matters for hair is the second one. Hyperandrogenism — androgen excess — is the part of PCOS that drives both the scalp hair loss and the unwanted body hair. A woman can have PCOS without prominent hair symptoms; but when hair symptoms appear, androgens are the reason.

Why PCOS affects hair: the androgen pathway

To understand PCOS hair loss you have to follow the hormones upstream. The trigger is not the ovary in isolation — it is insulin resistance, which a large proportion of women with PCOS have, lean or not [3].

The same elevated free testosterone, arriving at a facial or body follicle, does the opposite — it converts fine vellus hair into thick terminal hair, which is hirsutism. This is the androgen paradox: scalp follicles and body follicles are both androgen-sensitive, but they respond in opposite directions. One hormone signal, two opposite hair outcomes, both distressing. (The follicle-level biology of androgens and DHT is covered in DHT and hair loss explained.)

This is also why insulin resistance is the lever worth pulling: it sits at the top of the chain. Lower the insulin, and ovarian androgen output falls while SHBG rises — addressing the cause rather than the symptom.

What PCOS scalp hair loss looks like

PCOS scalp loss is a form of female pattern hair loss — androgen-driven pattern thinning — so it follows that distribution:

• Diffuse thinning across the top of the scalp, most obvious as a widening centre part and a more see-through crown.
• The frontal hairline is usually preserved — the loss is behind it, over the mid-scalp.
• It is graded on the Ludwig scale (I–III) or the more granular Sinclair scale (1–5) — the women’s classifications. The male Norwood scale does not apply, because PCOS loss does not produce temple recession or a bald crown.

What it is not: it is not patchy (coin-sized bare spots point to alopecia areata), and it is not primarily a sudden heavy shed. That said, PCOS involves hormonal fluctuation, and stopping a contraceptive pill or a significant weight change can trigger a telogen effluvium on top of the pattern loss — so the two can genuinely coexist and a dermatologist will tease them apart.

Alongside the scalp loss, the other androgenic skin signs are diagnostic clues: hirsutism (terminal hair on the upper lip, chin, jawline, chest, lower abdomen — formally scored with the modified Ferriman–Gallwey scale), persistent acne beyond the teenage years, and sometimes acanthosis nigricans (velvety dark skin in body folds, a marker of insulin resistance) [4].

Getting diagnosed: when hair loss points to PCOS

Any younger woman with pattern hair loss deserves a question set, because PCOS is a common and correctable cause. Suspect it when scalp thinning comes alongside:

• Irregular, infrequent or absent periods.
• Unwanted facial or body hair, or stubborn adult acne.
• Difficulty with weight, or a family history of PCOS or type 2 diabetes.
• Trouble conceiving.

The work-up is done by a GP, gynecologist or endocrinologist and typically includes blood tests for total and free testosterone, SHBG, and other androgens; tests to exclude mimics (thyroid disease, elevated prolactin, and — importantly — non-classic congenital adrenal hyperplasia, which can look like PCOS); an assessment of glucose and insulin or HbA1c; and a pelvic ultrasound. A dermatologist contributes the trichoscopy that confirms the hair loss is pattern (miniaturisation) rather than something else.

The key practical point: the hair complaint and the PCOS work-up belong together. Treating the scalp without diagnosing the PCOS underneath leaves the engine running.

What actually treats PCOS hair loss

The treatment toolkit, in plain terms:

• Anti-androgens — spironolactone is the most-used. It blocks androgen receptors at the follicle and modestly reduces androgen production. A 2023 systematic review of spironolactone for hair loss found consistent benefit across the literature, and it is a mainstay of androgenic alopecia management in women [5]. It must be paired with reliable contraception because of the risk to a male fetus.
• Combined oral contraceptives raise SHBG, which mops up free testosterone, and suppress ovarian androgen production. They treat the hyperandrogenism broadly — hair, acne and hirsutism together.
• Insulin-sensitising measures. For women carrying excess weight, a 5–10% reduction meaningfully improves the hormone profile; metformin is sometimes added for the metabolic side of PCOS.
• Topical minoxidil is the first-line drug for female pattern hair loss generally and works on the follicle directly, regardless of the hormonal situation — which makes it the option that fits around pregnancy planning. See the minoxidil complete guide.

Two honest caveats. First, none of this is fast — pattern hair loss treatments need 6–12 months before the verdict is in, and the first sign of success is usually that shedding settles and the loss stops getting worse, before any regrowth shows. Second, PCOS hair loss is a chronic-condition management problem: the treatments hold the result while they are used, and the result drifts back if they stop, because the underlying PCOS is still there.

What to expect

The encouraging part: PCOS hair loss tends to respond better than other forms of female pattern hair loss, because the androgen excess driving it is both larger and directly correctable. Lower the androgens at the source, block them at the follicle, and support regrowth with minoxidil, and many women see genuine, visible improvement — not just stabilisation.

But it is a marathon. Expect the timeline to run in seasons, not weeks: months 1–3 are about starting treatment and settling shedding; months 4–8 are where stabilisation becomes clear; months 9–12+ are where regrowth, if it is coming, becomes visible in photographs. Standardised monthly photos of the part-line, in the same light, are worth far more than daily mirror checks.

And the hair is one thread of a bigger condition. PCOS also carries long-term metabolic and cardiovascular considerations, and the same treatments that help the hair — particularly the insulin-sensitising side — help those too. That is the reframe worth holding: treating PCOS well is good for the hair, and treating the hair well means treating the PCOS.

What to read next

• Female Pattern Hair Loss: Complete Guide (2026) — the full picture of androgen-driven pattern thinning in women, with the Sinclair scale.
• Menopausal Hair Loss (2026) — the other major hormonal cause of women’s hair loss, at the opposite end of reproductive life.
• DHT and Hair Loss Explained (2026) — the follicle-level biology of androgens and miniaturisation.
• Telogen Effluvium: The Complete Guide (2026) — the shedding condition that can sit on top of PCOS pattern loss.

References

[1] Teede HJ, et al. “Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.” J Clin Endocrinol Metab. 2023;108(10):2447-2469.

[2] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).” Hum Reprod. 2004;19(1):41-47.

[3] Diamanti-Kandarakis E, Dunaif A. “Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.” Endocr Rev. 2012;33(6):981-1030.

[4] Housman E, Reynolds RV. “Polycystic ovary syndrome: a review for dermatologists. Part I. Diagnosis and manifestations.” J Am Acad Dermatol. 2014;71(5):847.e1-847.e10.

[5] Aleissa M, et al. “The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis.” Cureus. 2023;15(8):e43559.

Disclaimer: This article is educational, not diagnostic or prescriptive. PCOS is a medical diagnosis that requires bloodwork, an ultrasound and the exclusion of conditions that mimic it; its treatment — particularly anti-androgens and hormonal contraception — must be supervised by a doctor and planned around pregnancy intentions. Use this guide to have a more informed conversation with a GP, gynecologist, endocrinologist or dermatologist, not to self-treat.